glp 1 receptor agonists effects on cardiovascular risk reduction of Glucagon-Like Peptide-1 Impact of GLP-1 receptor agonists
Description
2019: The only oral GLP-1 RA, a semaglutide marketed under the brand name Rybelsus, is approved by the FDA
257 ShivaprasadHBhanumathyMSushmaGMidhunTRaveendraKSushmaKet al
GLP-1 microdosing generally involves doses lower than those outlined in standard prescribing guidelines, which makes it an off-label use
doi: 10.1093/cvr/cvae216, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 42
Viking Therapeutics Today VKTX Viking Therapeutics $37.08 +0.71 (+1.95%) As of 07/17/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $93.60 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months
Updated Contraception Advice for Mounjaro (Tirzepatide)
